Is variation in the gene encoding insulin-degrading enzyme (IDE) a risk factor in late-onset Alzheimer's disease?

被引：0
|
作者：
Nowotny, P
Smemo, S
Hinrichs, T
Holmans, P
Tracey, K
Doil, L
Grupe, A
Goate, A
机构：
[1] Washington Univ, Sch Med, St Louis, MO 63130 USA
[2] Univ Wales Coll Cardiff, Coll Med, Cardiff CF1 3NS, S Glam, Wales
[3] Celera Diagnost, Alameda, CA USA
来源：
NEUROBIOLOGY OF AGING | 2004年 / 25卷
关键词：
D O I：
10.1016/S0197-4580(04)81637-3
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S496 / S497
页数：2
相关论文
共 50 条
  • [41] APOE -: 491 promoter polymorphism is a risk factor for late-onset Alzheimer's disease
    Casadei, VM
    Ferri, C
    Veglia, F
    Gavazzi, A
    Salani, G
    Cattaneo, M
    Sorbi, S
    Annoni, G
    Licastro, F
    Mariani, C
    Franceschi, M
    Grimaldi, LME
    NEUROLOGY, 1999, 53 (08) : 1888 - 1889
  • [42] Plasma cholesterol and risk for late-onset Alzheimer's disease
    Cedazo-Minguez, Angel
    Ismail, Muhammad-Al-Mustafa
    Mateos, Laura
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (04) : 495 - 498
  • [43] Insulin-degrading enzyme in the Alzheimer's disease brain:: prominent localization in neurons and senile plaques
    Bernstein, HG
    Ansorge, S
    Riederer, P
    Reiser, M
    Frölich, L
    Bogerts, B
    NEUROSCIENCE LETTERS, 1999, 263 (2-3) : 161 - 164
  • [44] Metformin Ameliorates Aβ Pathology by Insulin-Degrading Enzyme in a Transgenic Mouse Model of Alzheimer's Disease
    Lu, Xin-Yi
    Huang, Shun
    Chen, Qu-Bo
    Zhang, Dapeng
    Li, Wanyan
    Ao, Ran
    Leung, Feona Chung-Yin
    Zhang, Zhimin
    Huang, Jisheng
    Tang, Ying
    Zhang, Shi-Jie
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020 (2020)
  • [45] P21 Gene Variation and Late-Onset Alzheimer's Disease in the Italian Population
    Scacchi, R.
    Gambina, G.
    Moretto, G.
    Corbo, R. M.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2013, 35 (1-2) : 51 - 57
  • [46] Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease
    Boussaha, M
    Hannequin, D
    Verpillat, P
    Brice, A
    Frebourg, T
    Campion, D
    NEUROSCIENCE LETTERS, 2002, 329 (01) : 121 - 123
  • [47] Neprilysin and Insulin-Degrading Enzyme Levels Are Increased in Alzheimer Disease in Relation to Disease Severity
    Miners, James Scott
    Baig, Shabnam
    Tayler, Hannah
    Kehoe, Patrick Gavin
    Love, Seth
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2009, 68 (08): : 902 - 914
  • [48] Insulin-degrading enzyme and Alzheimer disease - A genetic association study in the Han Chinese
    Bian, L
    Yang, JD
    Guo, TW
    Sun, Y
    Duan, SW
    Chen, WY
    Pan, YX
    Feng, GY
    He, L
    NEUROLOGY, 2004, 63 (02) : 241 - 245
  • [49] Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: Implications for Alzheimer's disease intervention
    Zhao, LX
    Teter, B
    Morihara, T
    Lim, GP
    Ambegaokar, SS
    Ubeda, OJ
    Frautschy, SA
    Cole, GM
    JOURNAL OF NEUROSCIENCE, 2004, 24 (49): : 11120 - 11126
  • [50] Degradation of Alzheimer's Amyloid-β by a Catalytically Inactive Insulin-Degrading Enzyme
    Sahoo, Bikash R.
    Panda, Pritam Kumar
    Liang, Wenguang
    Tang, Wei-Jen
    Ahuja, Rajeev
    Ramamoorthy, Ayyalusamy
    JOURNAL OF MOLECULAR BIOLOGY, 2021, 433 (13)
12345